Patents for C07C - Acyclic or carbocyclic compounds (5,682) |
---|
01/15/2009 | US20090018193 Essential fatty acids in the prevention of cardiovascular events |
01/14/2009 | EP2014285A1 NPYY5 antagonists |
01/14/2009 | CN101343243A Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates |
01/14/2009 | CN100451024C Metallocene compound, indene compound and application thereof |
01/07/2009 | CN101337900A Method of synthesizing camptothecin-relating compounds |
01/07/2009 | CN100448840C Brominated esters, methods for their preparation and use thereof as flame retardants |
01/06/2009 | US7473539 Methods for producing alkyl esters |
12/31/2008 | EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids |
12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
12/24/2008 | CN100445294C Platinum complex and luminescent element |
12/23/2008 | CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
12/17/2008 | EP1778813A4 Under-neutralized alkylxylene sulfonic acid composition for enhanced oil recovery processes |
12/17/2008 | CN101326267A Process for producing a saturated hydrocarbon component |
12/17/2008 | CN101326266A Process for producing a hydrocarbon component |
12/09/2008 | US7462643 Essential fatty acids in the prevention of cardiovascular events |
12/02/2008 | CA2305548C Prostaglandin agonists and their use to treat bone disorders |
11/27/2008 | US20080293961 Process for the purification of 1,4-butanediol mononitrate |
11/25/2008 | CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions |
11/20/2008 | US20080287711 Purification of Iodixanol |
11/12/2008 | EP1506171B1 Preparations of a sulfinyl acetamide |
11/05/2008 | EP1456168B1 Process for the continuous quaternisation of tertiary amines with an alkyl halide |
10/30/2008 | US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
10/29/2008 | CN101293867A Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
10/28/2008 | US7442797 Platinum complex and light emitting device |
10/28/2008 | US7442702 Prostaglandin agonists |
10/23/2008 | US20080262190 Method For the Manufacture of Oligo- and Polyesters From a Mixture of Carboxylic Acid Obtained From Suberin and/or Cutin and Use Thereof |
10/21/2008 | US7439407 Fluorinated pentacene derivative and method of producing same |
10/16/2008 | US20080255258 Polymerizing monoethylenically unsaturated compounds, crosslinking with an initiator, a crosslinker an acrylic monomer and styrene; functionalizing the acrylic bead polymers with diamines or aminoalcohols producing an ion exchange membrane |
10/15/2008 | CN100425609C N-heteroarylnicotinamide derivatives |
10/14/2008 | US7435854 Reacting venlafaxine with a high molecular weight alkyl, arylalkyl or aryl mercaptan anion (which may be generated by a metal alkoxide) in an alcohol or ether solvent; time and material efficient |
10/02/2008 | US20080242702 Paclitaxel enhancer compound |
09/23/2008 | US7427639 β2-adrenergic receptor agonists |
09/17/2008 | EP1021242B2 Device and process for producing liquid and, optionally, gaseous products from gaseous reactants |
09/17/2008 | CN101268045A Process for the preparation of peroxy acids |
09/17/2008 | CN101268041A Sulphonamide derivatives |
09/04/2008 | US20080214867 Purification of iodinated aryl compounds wherein the purification is performed by continuous crystallisation of the compound from a crude product in a solvent with removal of at least a fraction of the solvent; X-ray contrast agents; efficiency |
09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
09/03/2008 | CN100415735C Amino alcohol derivatives |
09/02/2008 | CA2356942C Preparation of iodixanol |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
08/28/2008 | US20080206827 Method for producing chiral a-hydroxycarboxylic crystalline acids |
08/27/2008 | EP1960349A1 Purification of iodixanol |
08/27/2008 | EP1959751A2 Use of fatty acid analogues |
08/27/2008 | EP1276719B1 Preparation of astaxanthin |
08/27/2008 | CN100413848C Acylsulfamoyl benzoic acid amides, plant protection agents containing same, and method for producing same |
08/21/2008 | US20080199402 Contrast Agents |
08/20/2008 | EP1249233B1 Npyy5 antagonists |
08/20/2008 | CN101248027A Continuous crystallisation process of iodinated phenyl derivatives |
08/20/2008 | CN101245058A Inhibitors of aspartyl protease |
08/14/2008 | US20080194876 Continuous Crystallisation Process of Iodinated Phenyl Derivatives |
08/06/2008 | EP1451143B1 Methods for preparing o-desmethylvenlafaxine |
07/30/2008 | CN101233092A Continuous crystallisation process of iodinated phenyl derivatives |
07/30/2008 | CN100406008C Pharmaceutical composition comprising lumiracoxib |
07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
07/24/2008 | US20080176949 Form V can be formed by crystallization from various solvents rather than by sublimation; depression |
07/24/2008 | US20080176338 Derivatives of diethylenetriaminepentaacetic acid such as penta-tert-butyl 2-{4'-{2-[4-carboxy-4-fluorenyl methyloxycarbonylamino)]butyrylamido}benzyl}diethylenetriamine-pentakis(acetate); solid phase synthesis |
07/16/2008 | CN101219962A Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
07/16/2008 | CN101218914A Plant protection agents |
07/16/2008 | CN100402498C Preparation of astaxanthin |
07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
07/16/2008 | CN100402474C Process for producing carbonyl & hydroxy compound |
07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
07/10/2008 | US20080167498 White crystals characterized by powder x-ray diffraction peaks at 12.8, 20.5, 21.3+-0.2 degrees two-theta; As inhibitor of re-uptake of norepinephrine and serotonin, used as anti-depressants |
07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
07/03/2008 | US20080161606 Preparation of iodixanol |
07/02/2008 | EP1937621A1 Method for the manufacture of oligo- and polyesters from a mixture of carboxylic acids obtained from suberin and/or cutin and the use thereof |
06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
06/25/2008 | CN100396664C Preparation process of 4,4'-diketo-beta-carotene derivative |
06/24/2008 | US7390923 novel non-steroidal propionanilide structured compounds; useful in hormonal therapy, male hypogonadism, andropause; 3-(4-Acetylamino-3-fluorophenoxy)-2-hydroxy-2-methyl-N-(3-methyl-4-nitrophenyl)propionamide; good water solubility; beneficial androgenic effects without harmful stimulation of prostate |
06/24/2008 | US7390647 Converting (R)- or (S)-cyanohydrins by enzymatic hydrolysis in presence of Rhodococcus erythropolis NCIMB 11540 into conjugate of alpha -hydroxycarboxylic acids; enantiomeric purity; carboxylation |
06/18/2008 | EP1931628A2 Process for the preparation of peroxy acids |
06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
06/10/2008 | CA2297838C Method of manufacturing phosphine compound |
06/04/2008 | EP1444181B1 Method for the preparation of n-propyl bromide |
06/04/2008 | CN101193847A Process for the preparation of adamantane derivatives |
06/04/2008 | CN100391930C 1, 3-propane diol derivatives as bioactive compounds |
06/04/2008 | CN100391433C Carotenoid composition and method for protecting skin |
06/03/2008 | US7381420 Labeling reactant |
05/28/2008 | EP1924554A1 Sulphonamide derivatives |
05/28/2008 | EP1924541A1 Continuous crystallisation process of iodinated phenyl derivatives |
05/28/2008 | CN101186590A Crystalline and pure modafinil, and process of preparing the same |
05/15/2008 | US20080114064 Tri(Hydroxymethyl)Methylamine Salt or an Ethanol Amine Salt of (2S)-2-Ethoxy-3-(4-PHENYL) Propanoic Acid |
05/13/2008 | US7371887 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly |
05/13/2008 | CA2293470C Benzimidazole derivatives |
05/06/2008 | US7368473 Paclitaxel enhancer compounds |
05/06/2008 | CA2306145C Amination process |
04/30/2008 | EP1915328A1 Continuous crystallisation process of iodinated phenyl derivatives |
04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
04/16/2008 | EP1470097B1 Pentabromobenzyl alkyl ethers and their use as fire retardants |
04/09/2008 | EP1299348B1 Compounds and compositions for delivering active agents |
04/09/2008 | CN101156861A Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
04/09/2008 | CN100379721C Preparations of a sulfinyl acetamide |
04/01/2008 | US7351858 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
04/01/2008 | US7351741 4-(4-chloro2-hydroxybenzoylamino)butyric acid or salts for delivering an agent that would otherwise be destroyed or rendered less effective by conditions encountered before the agent reaches its target zone |
03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
03/20/2008 | US20080070944 Novel methods using aminobenzoic acid compounds |
03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
03/19/2008 | EP1603651A4 Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine |
03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
03/18/2008 | CA2298493C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |